Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell costimulatory pathways: blockade for autoimmunity.

Nader Najafian1, Samia J Khoury

  • 1Laboratory of Immunogenetics and Transplantation, Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

Expert Opinion on Biological Therapy
|March 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upper Cervical Cord Area as a Biomarker of Conversion to Secondary Progressive Multiple Sclerosis.

Annals of clinical and translational neurology·2026
Same author

Retinal Optical Coherence Tomography Longitudinal Measures as Prognostic Biomarkers in Multiple Sclerosis: Systematic Review and Meta-Analysis.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal of neurology·2026
Same author

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

CNS drugs·2026
Same author

Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Therapeutic advances in neurological disorders·2026
Same author

Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Neurology·2026

T cell activation requires multiple signals, including those from the B7-CD28 superfamily. Understanding these costimulatory and inhibitory pathways is key to modulating immune responses and developing new therapies.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cellular Biology

Background:

  • T lymphocyte activation depends on T cell receptor (TCR) signaling and costimulatory receptor engagement.
  • Key pathways regulating T cell activation and tolerance include B7-1/B7-2-CD28, CTLA-4, CD154-CD40, and PD-1-PD-L1.
  • Novel B7-CD28 superfamily members influence responses of previously activated T cells.

Purpose of the Study:

  • To review current understanding of the B7-CD28 superfamily.
  • To discuss the therapeutic potential of B7-CD28 superfamily members.
  • To explore novel mechanisms regulating T cell responses in peripheral tissues.

Main Methods:

  • Literature review of B7-CD28 superfamily interactions.
  • Analysis of costimulatory and inhibitory signaling networks.

Related Experiment Videos

  • Examination of B7 homologue expression on non-APC cells.

    • Main Results:

    • The B7-CD28 superfamily plays a critical role in T cell activation, tolerance, and immune response modulation.
    • Integration of positive and negative costimulatory signals, including CTLA-4 and PD-1-PD-L1, shapes immune outcomes.
    • Expression of B7 homologues on non-professional APCs suggests novel regulatory mechanisms in peripheral tissues.

    Conclusions:

    • The B7-CD28 superfamily represents a complex network crucial for immune regulation.
    • Further research into these pathways holds significant therapeutic promise for immune-related diseases.
    • Understanding peripheral regulation by B7 homologues may reveal new therapeutic targets.